We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Abbott, AbbVie Must Produce Adverse Event Reports For AndroGel Testosterone

Mealey's (June 24, 2016, 11:42 AM EDT) -- CHICAGO — The Illinois federal judge overseeing the testosterone multidistrict litigation on June 22 granted a plaintiffs’ motion compelling defendants Abbott Laboratories and AbbVie Inc. to produce full drug safety and...
To view the full article, register now.